An exploratory randomized-controlled trial of the efficacy of the Src-kinase inhibitor saracatinib as a novel analgesic for cancer-induced bone pain

Danson, S. orcid.org/0000-0002-3593-2890, Mulvey, M.R., Turner, L. et al. (6 more authors) (2019) An exploratory randomized-controlled trial of the efficacy of the Src-kinase inhibitor saracatinib as a novel analgesic for cancer-induced bone pain. Journal of Bone Oncology. ISSN 2212-1374

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/).
Keywords: Cancer pain; Src inhibitor; Metastasis; Clinical trial; Saracatinib
Dates:
  • Accepted: 17 September 2019
  • Published (online): 18 September 2019
  • Published: 18 September 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Dentistry (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
FunderGrant number
Medical Research CouncilMR/K015052/1
Depositing User: Symplectic Sheffield
Date Deposited: 24 Sep 2019 11:03
Last Modified: 24 Sep 2019 11:03
Status: Published online
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jbo.2019.100261

Share / Export

Statistics